DIRS.INFO The most relevant business & tech news

☆ How previous investing mistakes are shaping my thinking on the latest stock gone wrong
▼ + stars: | 2024-05-05 | by ( Jim Cramer | ) www.cnbc.com time to read: +19 min

Three times a day we would gather "off the desk," and I would have to defend every stock we owned. First, there's the obvious mistakes that we have made: Bausch Health and Foot Locker . To signify the changes, he renamed it Bausch Health in 2018, after the eye-care company Valeant bought for $8.7 billion five years earlier. We thought the IPO market would come back, and Bausch Health would win the lawsuit and all would be back on track. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.

Persons: Jeff Marks, Karen Cramer, Cramer, Karen, Max Palevsky, It's, Joseph Papa, Clint Eastwood, Papa, Jim Cramer, Valeant, Bausch, Locker, Mary Dillon, Dillon, Wall, Emerson, Cristiano Amon, Laxman Narasimhan, Howard Schultz, Narasimhan, Benckiser, Kevin Johnson, Schultz, Johnson, it's, —, Foot Locker, Jim Cramer's, Jim Organizations: Cramer &, Intel, Charitable Trust, Co, Starbucks, Bausch Health, Pharmaceuticals, Perrigo, Health, Norwich Pharmaceuticals, Former, Emerson Electric, Qualcomm, National, Eaton Corp, Broadcom, Palestine, PepsiCo, Nestle, Elliott Management, Emerson, CNBC, Getty Locations: China, —, Israel, U.S, BHC, FL, Jinan, East China's Shandong province

☆ Interest rates and the AI-fueled rally remain top of mind for stock investors in the week ahead
▼ + stars: | 2024-05-03 | by ( Alex Harring | ) www.cnbc.com time to read: +9 min

The Fed and economic policy were top of mind this week given the central bank's Wednesday decision to yet again leave interest rates unchanged , as it has since last summer. This week included the conclusion of April's trading month, which marked the first down month of the year for all three major market averages. Indeed, some recent earnings reports have raised doubts about the economy, with brands from McDonald's and Starbucks evidencing signs of strain among consumers. While no new inflation numbers are scheduled for release next week, investors will see reports on March wholesale inventories, March consumer credit and May consumer sentiment from the University of Michigan. AI trade Though interest rates took center stage this week, investors also continued monitoring companies tied to the artificial intelligence boom amid the stocks' recent choppiness.

Persons: they're, Jerome Powell, Larry Tentarelli, David Donabedian, Sam Stovall, There's, Stovall, Tom Hainlin, Tentarelli, CFRA's Stovall, Lyft, Cabot, Aramark, Tempur Sealy, Nikola, Walt Disney, Sally Beauty, Warby Parker, Krispy Kreme, Papa John's Organizations: Federal Reserve, Treasury, Nasdaq, Dow Jones, CIBC Private Wealth, Dow, CFRA, Citigroup, Bank of America, U.S, Bank Wealth Management, University of Michigan, Nvidia, Disney, Spirit Airlines, Tyson Foods, Pharmaceuticals, Lucid, Palantir Technologies, Simon Property, Tech, Lab, Goodyear Tire, Noble Corp, Vornado Realty, Coty, BellRing, Consumer, UBS, BP, Nintendo, Bloomin, Duke Energy, Rockwell Automation, Ferrari, NRG Energy, Electronic Arts, Cirrus, Adaptive Biotech, Arista Networks, Dutch Bros, Holdings, Virgin Galactic, IAC, Rivian Automotive, Brighthouse, Occidental Petroleum, Assurant, Kinross Gold, Labs, Diamond, Reddit, Anheuser, Busch InBev, Embraer, Health, United Parks & Resorts, Emerson Electric, Brookfield , New York Times, Food, Reynolds Consumer Products, Teva Pharma, Uber Technologies, Dine Brands, Liberty Broadband, Fox Corp, Cushman &, Liberty Media, Arm Holdings, Kodiak Gas Services, Solaredge Technologies, AMC Entertainment, Cheesecake, News Corp, Toyota Motors, Fair, US Foods, Hyatt Hotels, Warner Bros, Hilton, Warner Music Group, Unity Software, Insurance, Gen, Honda, AMC Networks Locations: Central, McDonald's, Expeditors, Occidental, Angi, Brookfield , New, Ambev, Cushman & Wakefield, Michigan

☆ Why the WNBA wants more people to know about the new over-the-counter birth control pill
▼ + stars: | 2024-04-09 | by ( Jacqueline Howard | ) edition.cnn.com time to read: +6 min

CNN —As the first over-the-counter birth control pill in the United States hits store shelves, the company behind the product, Perrigo, is taking steps to ensure women are aware of this new contraception option. It’s a different formulation than what is in combination hormonal birth control pills, which contain both progestin and estrogen. Combined birth control pills may carry risks for people with uncontrolled hypertension or blood clot risks for smokers older than 35. Most birth control pills are up to 99% effective at preventing pregnancy if taken as instructed. “I’m always a little skeptical of Big Pharma and their partnerships, but I think the general principle of having highly effective over-the-counter birth control be over the counter, that’s empowering” she said.

Persons: “ We’re, Opill, ”, Colie Edison, “ We’ve, Leila Bahbah, ” Edison, “ we’re, “, ‘, ’, Roe, Wade, prescribers, Joe Biden, Dobbs, Dr, Sanjay Gupta, Colleen Denny, Denny, “ I’m, ” Denny Organizations: CNN, WNBA, “, ESPN, US Food and Drug Administration, Jackson, Health Organization, White, Get CNN, CNN Health, NYU Langone Hospital –, Big Pharma Locations: United States, Dobbs v, “

☆ Many CVS drug plans will cover over-the-counter birth control pill at no cost
▼ + stars: | 2024-04-04 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

CVS Health on Thursday said its drug plans will cover the first over-the-counter birth control pill in the U.S. at no cost for many health plan sponsors, a decision that could open the door for more people to prevent unintended pregnancies without a prescription. The company's pharmacy benefit manager, CVS Caremark, said the pill will be added to its preventive services oral contraceptives list and will be covered at zero cost for many sponsors. Pharmacy benefit managers, or PBMs, maintain lists of drugs covered by health insurance plans and negotiate drug discounts with manufacturers. It marks the first time that many U.S. residents are able to buy birth control pills over the counter, the same way they would purchase common pills like Tylenol or Advil. The drug could significantly expand availability of contraception, especially for younger women and those in rural and underserved communities who often have trouble getting access to birth control methods.

Persons: Opill, Biden, Wade Organizations: CVS, CVS Caremark, CNBC, Pharmacy, Drug Administration Locations: San Anselmo , California, U.S, Perrigo

☆ 2 experts suggest these 8 side hustles to try this year if you're looking to make money outside your job
▼ + stars: | 2024-03-16 | by ( Madison Hoff | ) www.businessinsider.com time to read: +10 min

AdvertisementSide hustles can include building a profitable business, spending a few minutes on an online gig like survey work, or working a job that falls outside your typical 9-to-5. AdvertisementPet sitting or other kinds of care workAnother side job could be watching someone's pets or care-related side hustles. AdvertisementFood deliveryThere are several food delivery platforms people can try as a side job, such as Uber Eats. "You may be really passionate about art or that creative side, but that's not something that you do in your day job," Caban said. Have you made money from a side job or a side hustle?

Persons: Instawork's Kira Caban, Ted Rossman, —, Kira Caban, it's, Gen Zers, Rossman, Caban, Davis, Taylor Swift, Scott, Meghan Lim, Lim, Uber, Erin Couch, Couch Organizations: Service, Instawork, Business, BI, Baseball, Connect Locations: Nashville

☆ You'll soon be able to get birth control without a prescription. Here's what you need to know.
▼ + stars: | 2024-03-04 | by ( Allie Kelly | ) www.businessinsider.com time to read: +5 min

It is the first hormonal birth control available for retail and will expand access. Prescription-free birth control will expand accessThe introduction of Opill to family planning aisles will lower barriers to birth control. Since Opill is available without a prescription, people will no longer have to pay a doctor or pharmacist to access hormonal birth control. She urged policymakers to make sure non-prescription birth control is covered by insurance and assistance programs. AdvertisementProgestin-only birth control also carries a risk of ectopic pregnancy and can increase a person's risk for breast cancer, regardless of medical history.

Persons: —, Opill, Victoria Nichols, Nichols, Dr, Tania Serna Organizations: Amazon, Walgreens, CVS, Target, Walmart, Service, US Food and Drug Administration, Guttmacher, Guttmacher Institute, Affordable Care, Kaiser Family Foundation, The American College of Obstetricians, OB, University of California Locations: San Francisco

Powdered drink mixes that are widely promoted as “toddler milks” for older babies and children up to age 3 are unregulated, unnecessary and “nutritionally incomplete,” the American Academy of Pediatrics warned Friday. Also, toddler drinks are different than medical formulas prescribed for specific conditions, such as heart disease or problems digesting certain foods. Fuchs and other experts point to the lack of common standards for toddler milks, which means the ingredients vary widely among brands. The group also wants requirements to ensure the products are not linked to regulated infant formula or sold next to formula. A health group petitioned the FDA in 2020 to regulate toddler milks, but the agency is still reviewing the request.

Persons: George Fuchs, Fuchs, milks, ”, Frances Fleming, Milici, “ They’re, Fleming, “ Organizations: American Academy of Pediatrics, U.S . Food, Drug Administration, Rudd Center for Food Policy, Health, University of Connecticut, University of Kentucky, Infant Nutrition Council of America, Abbott Nutrition, Perrigo, AAP, Associated Press Health, Science Department, Howard Hughes Medical Institute’s Science, Educational Media Group, AP

☆ Lightning Round: Palantir actually lived up to its hype, says Jim Cramer
▼ + stars: | 2023-10-02 | by ( Jim Cramer | ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailLightning Round: Palantir actually lived up to its hype, says Jim Cramer'Mad Money' host Jim Cramer weighs in on stocks including: Energy Transfer, Perrigo, Robinhood, Palantir, PacWest and more.

Persons: Palantir, Jim Cramer

☆ Cramer's Lightning Round: Stay away from PacWest Bancorp
▼ + stars: | 2023-10-02 | by ( Julie Coleman | ) www.cnbc.com time to read: +1 min

Stock Chart Icon Stock chart icon Energy Transfer's year-to-date stock performance. Stock Chart Icon Stock chart icon Perrigo's year-to-date stock performance. Stock Chart Icon Stock chart icon Robinhood's year-to-date stock performance. Stock Chart Icon Stock chart icon Palantir's year-to-date stock performance. Stock Chart Icon Stock chart icon PacWest Bancorp's year-to-date stock performance.

Persons: PacWest, Kratos, Jim Cramer's Organizations: Energy, Costco

☆ US FDA warns 3 baby formula makers to correct manufacturing process controls
▼ + stars: | 2023-08-30 | by ( ) www.reuters.com time to read: +2 min

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. The FDA pulled up these companies for failing to establish processes to ensure infant formula does not become contaminated during manufacturing. The recalls were meant to remove products potentially contaminated with the bacteria cronobacter sakazakii, the FDA added. "The agency... believes that the recalls were effective in removing the potentially contaminated batches of product from the market," the FDA said. Infant formula manufacturing is under greater scrutiny following the shortage of the product last year due to a shutdown of Abbott Laboratories' (ABT.N) unit in Michigan.

Persons: Andrew Kelly, Benckiser, Mead Johnson, Perrigo, ByHeart, Leroy Leo, Krishna Chandra Organizations: Food and Drug Administration, FDA, REUTERS, U.S . Food, Drug Administration, ByHeart Inc, Mead Johnson Nutrition, Abbott Laboratories, Thomson Locations: White Oak , Maryland, U.S, PRGO.N, Wisconsin, Michigan, Bengaluru

☆ Opill: The FDA approved the US’ first over-the-counter birth control pill. What happens next?
▼ + stars: | 2023-07-21 | by ( Amanda Musa | ) edition.cnn.com time to read: +8 min

CNN —The US Food and Drug Administration has approved the oral contraceptive Opill for over-the-counter use, making it the first nonprescription birth control pill in the United States, but it will be months before it’s available. The typical combination birth control pill, the most commonly used form of oral contraception, uses both hormones to prevent pregnancy. “People use birth control for things outside of preventing pregnancy like [polycystic ovary syndrome], treating heavy periods, painful periods,” she said. “There’s a lot of uses for it outside of birth control that people also will benefit if they can get it over the counter.”Who can use Opill? This could have a major impact for adolescents and young adults who may not otherwise have the resources to access birth control, according to Brandi.

Persons: Gynecologists, ” ACOG, Carolyn Westhoff, they’re, “, ”, Opill, Kristyn Brandi, Brandi, ” Brandi, Anne, Marie Amies Oelschlager, Amies Oelschlager, Jennifer Robinson, ” Robinson, Frederique, Joe Biden, Court’s Dobbs, Dr, Sanjay Gupta, Meg Tirrell Organizations: CNN, Food and Drug Administration, American College of Obstetricians, FDA, Columbia University, Physicians for Reproductive Health, Gynecology, of Gynecology, Johns Hopkins University, Treasury, Labor, Human, CNN Health Locations: United States, Opill, New Jersey

☆ Insurance may not cover birth control drug Opill without prescription
▼ + stars: | 2023-07-15 | by ( Spencer Kimball | ) www.cnbc.com time to read: +1 min

The first birth control pill sold without a prescription in the U.S. could remain out of reach for some women and girls because health insurance plans are not required to cover the medication in its over-the-counter form. But some women and girls could still face barriers to obtain Opill. The Affordable Care Act does not require private health insurance to cover the cost of the pill when used without a prescription. Most health insurers are required to offer birth control for free when prescribed by a doctor. State Medicaid programs are also generally not required to cover drugs sold without prescription, according to the federal Centers for Medicare & Medicaid Services.

Persons: Perrigo, Frederique Welgryn, Welgryn Organizations: U.S . Food, Drug Administration, Women's Health, Perrigo, Medicare, Medicaid Services Locations: U.S

☆ You'll now be able to get birth control without a prescription — but it won't hit store shelves until 2024
▼ + stars: | 2023-07-13 | by ( Associated Press | ) www.businessinsider.com time to read: +4 min

The FDA approved the first over-the-counter birth control pill. Advocates pushed for expanding birth control access, especially with more restrictions on abortion. U.S. officials have approved the first over-the-counter birth control pill, which will let American women and girls buy contraceptive medication from a retail store without a prescription. But women's health advocates hope the decision will pave the way for more over-the-counter birth control options and, eventually, for abortion pills to do the same. Newer birth control pills typically combine two hormones, estrogen and progestin, which can help make periods lighter and more regular.

Persons: Perrgio's, Perrigo's, Perrigo, Opill —, Roe, Wade, Opill Organizations: FDA, Drug Administration Locations: Ireland

July 13 (Reuters) - The U.S. Food and Drug Administration on Thursday approved the first over-the-counter contraceptive pill, paving the way for millions of women in the country to purchase birth control without prescription. Perrigo will next week share its pricing plan for the pill, which will be available in stores and online in the first quarter of next year. Women should take a progestin-only pill within the same three hours every day to avoid pregnancy. The National Catholic Bioethics Center and other groups have opposed making Opill available without prescription, saying physicians should be involved in health decisions, especially for teenagers, along with parental supervision, to avoid harm. Perrigo gained the daily-use pill first through its $2.13 billion acquisition of Paris-based HRA Pharma in 2021.

Persons: Roe, Wade, Xavier Becerra, Opill, Jeffrey Singer, Perrigo, Manas Mishra, Sriparna Roy, Arun Koyyur Organizations: U.S . Food, Drug Administration, Perrigo, Human Services, Cato Institute, FDA, Catholic Bioethics Center, HRA Pharma, Thomson Locations: U.S, Paris, Bengaluru

☆ FDA approves first over-the-counter birth control pill
▼ + stars: | 2023-07-13 | by ( Carma Hassan | ) edition.cnn.com time to read: +3 min

CNN —The US Food and Drug Administration on Thursday approved the birth control pill Opill to be available over-the-counter — the first nonprescription birth control pill in the United States. Opill is expected to be available over-the-counter in stores by the end of March 2024. The FDA has faced pressure to allow Opill to go over-the-counter from lawmakers as well as health care providers. A recent study showed that it has become harder for women to access reproductive health care services more broadly — such as routine screenings and birth control — in recent years. About 45% of women experienced at least one barrier to reproductive health care services in 2021, up 10% from 2017.

Persons: “, Patrizia Cavazzoni, “, ”, Frederique Welgryn, Opill, Welgryn, Perrigo, Dr, Sanjay Gupta, —, Meg Tirrell Organizations: CNN, Food and Drug Administration, FDA’s Center, Drug, Research, FDA, CNN Health Locations: United States, U.S

☆ FDA approves Opill, the first over-the-counter birth control pill
▼ + stars: | 2023-07-13 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

HRA Pharma expects a final decision by the FDA this summer on its application for nonprescription sales of Opill, which is generically called norgestrel. The Food and Drug Administration on Thursday approved the first over-the-counter birth control pill, a landmark decision that will allow more women and girls in the U.S. to prevent unintended pregnancies without a prescription. The daily pill, called Opill, was first approved by the FDA as a prescription in 1973. Medical organizations like the American College of Obstetricians and Gynecologists and women's health advocates have pushed for wider access. More than 50 members of Congress in March 2022 also called on FDA Commissioner Dr. Robert Califf to ensure the agency reviewed applications for over-the-counter birth control pills without delay.

Persons: Biden, Wade, –, Welgryn, Robert Califf, Patrizia Cavazzoni, Opill Organizations: HRA Pharma, FDA, Drug Administration, American College of Obstetricians, FDA's Center, Drug, Research Locations: U.S, Paris, Dublin

☆ F.D.A. Approves First U.S. Over-the-Counter Birth Control Pill
▼ + stars: | 2023-07-13 | by ( Pam Belluck | More About Pam Belluck | ) www.nytimes.com time to read: +1 min

The Food and Drug Administration on Thursday approved a birth control pill to be sold without a prescription for the first time in the United States, a step that could significantly expand access to contraception. The medication, called Opill, will become the most effective birth control method available over the counter — more effective at preventing pregnancy than condoms, spermicides and other nonprescription methods. Experts in reproductive health said its availability could be especially useful for young women, teenagers and those who have difficulty dealing with the time, costs or logistical hurdles involved in visiting a doctor to obtain a prescription. The pill’s manufacturer, Perrigo Company, based in Dublin, said Opill would most likely become available from stores and online retailers in the United States in early 2024. The company did not say how much the medication would cost — a key question that will help determine how many people will use the pill — but Frédérique Welgryn, Perrigo’s global vice president for women’s health, said in a statement that the company was committed to making the pill “accessible and affordable to women and people of all ages.” Ms. Welgryn has also said the company would have a consumer assistance program to provide the pill at no cost to some women.

Persons: Opill, Ms, Welgryn Organizations: Drug Administration, Perrigo Locations: United States, Dublin

☆ Taylor Swift's album release 'Speak Now (Taylor's Version)' comes during her very good, un-'cruel summer'
▼ + stars: | 2023-07-06 | by ( Alli Rosenbloom | ) edition.cnn.com time to read: +7 min

And on Friday, the throwback Swift love continues, when the beloved singer-songwriter releases her hotly-anticipated “Speak Now (Taylor’s Version)” album, a re-record of her 2010 hit album. While I haven’t yet seen the “Eras Tour,” I managed to secure tickets to an upcoming August show in Los Angeles. Taylor Swift performing the 'Eras Tour' in New Jersey in May. Swifies react to hearing Taylor Swift's 'Eras Tour' set begin from the parking lot of Philadelphia's Lincoln Financial Field in May. Taylor Swift performing the 'Eras Tour' in Cincinnati in June.

Persons: Taylor Swift, –, Swift, ” Alan Light, ”, I’ve, Kevin Mazur, ” Swift, John ” –, John Mayer –, ” Taylor Swift, ” She’s, it’s Swift, “, Taylor Swift's, Rachel Wisniewski, what’s, “ Taylor, David Perrigo, ” Perrigo, Swifties, it’s, Taylor Organizations: CNN, Stone, Swift, CNN Entertainment, Chicago’s, Pride, Lincoln Financial Field, Washington Post, Pittsburgh’s, Nashville, Nissan Locations: Pittsburgh, Los Angeles, New Jersey, Minneapolis, Philadelphia, ”, Chicago, Atlanta , New Jersey, Swifties, Cincinnati

☆ Abortion Bans Can Help Make This Cheap, Accessible Birth Control Pill a Hit
▼ + stars: | 2023-05-14 | by ( David Wainer | ) www.wsj.com time to read: 1 min

WSJ’s Daniela Hernandez explains how over-the-counter access could affect reproductive care across the U.S. Photo: Laura KammermannAs efforts to crack down on abortion increase around the U.S., contraceptives are bound to play an increasingly important role in family planning. But for many women, cost and access are still prohibitive factors. A cheaper, over-the-counter option could help close that gap while creating a sizable market for generic drugmaker Perrigo . Advisers to the Food and Drug Administration earlier this week recommended that Perrigo’s oral contraceptive, called Opill, be made available without prescription. If the recommendation is adopted by the FDA, it would help widen access to birth control around the country.

☆ Perrigo CEO Murray Kessler: Over-the-counter birth control is a 'historic opportunity for women'
▼ + stars: | 2023-05-12 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailPerrigo CEO Murray Kessler: Over-the-counter birth control is a 'historic opportunity for women'Murray Kessler, Perrigo President & CEO, joins 'Closing Bell Overtime' to discuss the FDA's recommendation of Opill, an over the counter birth control pill, as well as new safety measures in baby formula manufacturing.

☆ U.S. FDA advisers back OTC use of Perrigo's birth control pill
▼ + stars: | 2023-05-10 | by ( ) www.reuters.com time to read: +1 min

May 10 (Reuters) - A U.S. Food and Drug Administration advisory panel on Wednesday voted in favor of using Perrigo Co's (PRGO.N) contraceptive without a prescription, paving the way for the country's first approval for an over-the-counter birth control pill. The panel remained positive on the effectiveness of the pill, not only in the general population of women but also in adolescent populations and those with limited literacy. Perrigo's Opill, currently approved for prescription use, would be the first OTC non-estrogen contraceptive pill in the United States if approved by the regulator. The FDA generally follows the advise of its experts, though it is not bound to do so. Reporting by Sriparna Roy and Nandhini Srinivasan in Bengaluru; Editing by Shailesh KuberOur Standards: The Thomson Reuters Trust Principles.

☆ FDA advisors recommend sale of birth control pill without a prescription
▼ + stars: | 2023-05-10 | by ( Spencer Kimball | ) www.cnbc.com time to read: +3 min

A panel of experts who advise the Food and Drug Administration unanimously recommended Wednesday that the agency for the first time allow women to obtain a birth control pill without a prescription. The panel had been asked whether the benefits of selling HRA Pharma's birth control pill Opill outweighed the risks of consumers improperly using the medication resulting in unintended pregnancy. Medical associations such as the American College of Obstetricians and Gynecologists for years have urged over-the-counter sales of birth control pills be allowedMore than 50 members of Congress in March 2022 called on FDA Commissioner Dr. Robert Califf to ensure the agency reviewed applications for over-the-counter birth control pills without delay. "Despite decades of proven safety and effectiveness, people still face immense barriers to getting birth control due to systemic inequities in our healthcare system." Shrinking access to abortion across the U.S. in turn sparked renewed calls for expanded access to birth control to prevent unwanted pregnancies.

☆ F.D.A. Advisers Weigh Allowing First U.S. Over-the-Counter Birth Control Pill
▼ + stars: | 2023-05-09 | by ( Pam Belluck | ) www.nytimes.com time to read: +1 min

It was like a tale of two birth control pills. At a hearing Tuesday to consider whether the Food and Drug Administration should authorize the country’s first over-the-counter birth control pill, a panel of independent medical experts advising the agency was left to reckon with two contradictory analyses of the medication called Opill. During the eight-hour session, the manufacturer of the pill, HRA Pharma, which is owned by Perrigo, and representatives of many medical organizations and reproductive health specialists said that data strongly supported approval. scientists questioned the reliability of company data that was intended to show that consumers would take the pill at roughly the same time every day and comply with directions to abstain from sex or temporarily use other birth control if they missed a dose. “I’m just really quite confused by the level of discrepancy,” one member of the advisory panel, Pamela Shaw, a senior investigator with Kaiser Permanente Washington, said after both sides had made presentations.

☆ FDA may allow birth control pill without prescription this summer as experts weigh data
▼ + stars: | 2023-05-09 | by ( Spencer Kimball | ) www.cnbc.com time to read: +2 min

The Food and Drug Administration could approve the sale of birth control medication without a prescription for the first time by this summer. The FDA approved prescription sales of HRA Pharma's birth control pill in 1973. Medical associations such as the American College of Obstetricians and Gynecologists for years have supported over-the-counter access to birth control without age restrictions. In March 2022, more than 50 members of Congress urged FDA Commissioner Dr. Robert Califf to review applications for over-the-counter sales of birth control without delay. "Despite decades of proven safety and effectiveness, people still face immense barriers to getting birth control due to systemic inequities in our healthcare system."

☆ As earnings season winds down, investors turn to Tuesday's debt ceiling meeting
▼ + stars: | 2023-05-06 | by ( Zev Fima | ) www.cnbc.com time to read: +12 min

With only a small fraction of the S & P 500 left to report quarterly earnings, investors are now turning their focus to another major hurdle for the markets and economy: the debt ceiling crisis. Earlier this week, we looked back to debt limit crisis of 2011 for potential lessons. The protracted fight ultimately ended in an agreement in early August of that year, but it was a choppy summertime ride for investors. Within the portfolio, Wynn Resorts will report Tuesday, after the closing bell, and Disney will report on Wednesday, after the closing bell. Estee Lauder (EL) and Emerson Electric (EMR) reported earnings before the opening bell.

Search resuls for: "Perrigo"

25 mentions found